5-amino-1mq nnmt snp rsid 5mg & 50mg | Inhibitor Research Compound 5-Amino-1MQ NNMT Inhibitor Tablets

Research is ongoing and the peptide doesnt have FDA approval

The peptide does not appear to significantly affect glucose metabolism or insulin sensitivity in the way that full-length growth hormone does - growth hormone causes insulin resistance through various mechanisms, whereas AOD9604 has been reported to be neutral or possibly even beneficial for insulin sensitivity

Considering that IGF-1 regulates IGFBP-1 and IGFBP-2, it is reasonable to conclude that early changes in insulin resistance alter their concentrations

All Xcel Peptides products are intended strictly for laboratory and scientific research use only

Coverage with HSA or FSA accounts varies, depending on your coverage plan